Add Yahoo as a preferred source to see more of our stories on Google. Cancer remains one of humanity's most formidable challenges, claiming the lives of millions every year despite decades of medical ...

A new cohort study suggests that Medicaid expansion is associated with a lower mortality risk among patients with pancreatic ...

The MarketWatch News Department was not involved in the creation of this content. Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Dec. 12, 2025 /PRNewswire/ -- USANewsGroup.com News ...

A phase 3 trial found that adding chemoradiotherapy (CRT) after induction chemotherapy in patients with unresectable pancreatic cancer did not extend overall survival compared to chemotherapy alone ...

The word "cancer" is scary regardless of the type, but few types of cancer are as lethal as pancreatic cancer. Based on estimates from the American Cancer Society in 2013, an estimated 45,220 people ...

Atebimetinib combined with modified chemotherapy achieved a 94% six-month overall survival rate in first-line pancreatic cancer patients, surpassing the typical 67% with standard treatment. The ...

Pancreatic cancer survival has finally doubled in a decade to 13 percent, a fragile but real sign that years of slow, methodical progress are beginning to add up. November is Pancreatic Cancer ...

A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a ...

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Dec. 12, 2025 /PRNewswire/ -- USANewsGroup.com News Commentary – Scientists developed an antibody treatment that reawakens the immune system ...